Want to see EFTR full AI Analyst Report?
eFFECTOR Therapeutics (EFTR) Q2 2023 Earnings Report
EFTR Q2 2023 EPS Results
- Actual EPS
- -$4.25
- Consensus EPS
- -$4.95
- Beat/Miss
- Beat by +$0.70
- One Year Ago EPS
- -$4.25
EFTR Q2 2023 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/08/2023
- Time
- After Close
- Conference Call
- Tuesday, August 8, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
EFTR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| May 13, 2025 | 2025 (Q1) | ―- | -2.16 | ― | |
| Mar 12, 2025 | 2024 (Q4) | ―- | ― | ― | |
| Nov 04, 2024 | 2024 (Q3) | ―- | ― | ― | |
| Aug 06, 2024 | 2024 (Q2) | -2.02- | -4.25 | ― | |
| May 09, 2024 | 2024 (Q1) | -2.17-2.16 | -6 | 64.00% (+3.84) | |
| Mar 25, 2024 | 2023 (Q4) | -2.82-3.42 | -5.5 | 37.82% (+2.08) | |
| Nov 13, 2023 | 2023 (Q3) | -3.08-3.25 | -5.75 | 43.48% (+2.50) | |
| Aug 08, 2023 | 2023 (Q2) | -4.95-4.25 | -4.25 | 0.00% (+0.00) | |
| May 09, 2023 | 2023 (Q1) | -5.08-6.00 | 1.75 | -442.86% (-7.75) | |
| Mar 08, 2023 | 2022 (Q4) | -5.95-5.50 | 11 | -150.00% (-16.50) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
